[
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02879695\">A Phase 1 Study of Blinatumomab in Combination with Checkpoint Inhibitor(s) of PD-1 (Nivolumab) or Both PD-1 (Nivolumab) and CTLA-4 (Ipilimumab) in Patients with Poor-Risk, Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03030378\">A Phase 1 Study of Pembrolizumab (MK-3475) in Combination with Recombinant Interleukin-12 in Patients with Solid Tumors</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03606967\">Randomized Phase 2 Clinical Trial of Nab-Paclitaxel + Durvalumab (MEDI4736) + Tremelimumab + Neoantigen Vaccine Vs. Nab-Paclitaxel + Durvalumab (MEDI4736) + Tremelimumab in Patients with Metastatic Triple Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03939897\">A Randomized Phase I/II Trial of Fulvestrant and Abemaciclib in Combination with Copanlisib (FAC) Versus Fulvestrant and Abemaciclib Alone (FA) for Endocrine-Resistant, Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer (FAC vs FA)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03907475\">DURVA+ : Evaluation of the Safety and Pharmacodynamics of Anti-PD-L1 Antibody Durvalumab in Combination with Chemotherapy in Patients with Advanced Solid Tumors</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04071236\">A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, & Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04340843\">A Phase 2 Study of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma</a>",
        "Disease Type": "Bone Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04535401\">Phase I/Ib Trial of ATR Inhibitor BAY 1895344 in Combination with FOLFIRI in GI Malignancies with a Focus on Metastatic Colorectal and Gastric/Gastroesophageal Cancers</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05333458\">A Randomized Phase 2 Study of Atezolizumab with or Without Selinexor in Alveolar Soft Part Sarcoma (AXIOM)</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05432804\">A Phase 1 and Randomized Phase 2 Trial of Selinexor and Temozolomide in Recurrent Glioblastoma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05019716\">A Phase 1/2 Study of the Bromodomain Inhibitor ZEN003694 in Combination with Etoposide/Platinum in Patients with NUT Carcinoma</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05564416\">An Open Label, Randomized Phase II Study Neoadjuvant Erdafitinib with or Without Atezolizumab in Cisplatin-Ineligible Patients with Muscle Invasive Bladder Cancer (NERA)</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02595879\">Phase I Dose-Escalation Bioavailability Study of Oral Triapine in Combination with Concurrent Chemoradiation for Locally Advanced Cervical Cancer (LACC) and Vaginal Cancer</a>",
        "Disease Type": "AIDS-related Malignancy and Condition;Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04340141\">A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04665739\">Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04803201\">A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02523014\">Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas with SMO/ AKT/ NF2/CDK Pathway Mutations</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03944941\">Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC)</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05111574\">A Randomized Phase II Trial of Adjuvant Nivolumab with or Without Cabozantinib in Patients with Resected Mucosal Melanoma</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated with First-Line MK-3475 (Pembrolizumab)+/- Chemotherapy (Oncologist's/Patient's Choice)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04711109\">BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to determine the Preventive Effect of Denosumab on Breast Cancer in Women carrying a BRCA1 Germline Mutation</a>",
        "Disease Type": "N/A",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Blinded Reference Set For Multicancer Early Detection Blood Tests</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05077527\">Axicabtagene Ciloleucel in Relapsed or Refractory HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphoma</a>",
        "Disease Type": "AIDS-related Malignancy and Condition",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)</a>",
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma);Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04266249\">EA1181 (CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response Part 1 Component of: The CompassHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03604991\">A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04175912\">A Phase 2 Study of Pevonedistat in Combination with Carboplatin and Paclitaxel in Advanced Intrahepatic Cholangiocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04858334\">APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03191149\">Phase II Study of AZD9291 (Osimertinib) in Advanced NSCLC Patients with Exon 20 Insertion Mutations in EGFR</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02339571\">Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02305654\">InPACT- International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04628767\">A Phase II/III Trial of Durvalumab and Chemotherapy for Patients with High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05538663\">A Randomized Phase III Trial of Intravesical BCG VeRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Na\u00efve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03937635\">Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05327686\">Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03997370\">Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03389802\">Phase I Study to Evaluate the Safety and Tolerability of the CD40 Agonistic Monoclonal Antibody APX005M in Pediatric Subjects with Recurrent/Refractory Brain Tumors and Newly Diagnosed Brain Stem Glioma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04870944\">A Phase 1/2 Trial of CBL0137 (NSC# 825802) in Patients with Relapsed or Refractory Solid Tumors Including CNS Tumors and Lymphoma</a>",
        "Disease Type": "Bone Cancer;CNS Cancer (Primary tumor);Lymphoma;Solid Tumor",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT01349881\">A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon or Rectal Cancer, Phase III- Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04315324\">A Phase I/II Study of AKR1C3-Activated Prodrug OBI-3424 (OBI-3424) In Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL)/T-Cell Lymphoblastic Lymphoma (T-LBL)</a>",
        "Disease Type": "Leukemia;Lymphoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04310020\">A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04579224\">A Phase III Randomized Trial of Eribulin (NSC #707389) with or Without Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04840602\">A Phase II Randomized Study of Ibrutinib and Rituximab with or Without Venetoclax in Previously Untreated Waldenstr\u00f6m's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL)</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05058651\">Randomized Phase II/III Trial of First Line Platinum/Etoposide with or Without Atezolizumab (NSC#783608) in Patients with Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study</a>",
        "Disease Type": "N/A",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03803774\">Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04092270\">A Phase I/Ib Dose Escalation Study of Pegylated Liposomal Doxorubicin (PLD) with Peposertib (M3814) in Platinum - Resistant or Ineligible Ovarian and Related Cancers with Planned Expansions in High Grade Serous (HGSOC) and Low Grade Serous Ovarian Cancer (LGSOC)</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04250545\">A Phase I Trial of MLN0128 (Sapanisertib) and Telaglenastat (CB-839) HCL in Advanced NSCLC Patients</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04301076\">A Phase 1 Study of Lenalidomide in Combination with EPOCH Chemotherapy for HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL)</a>",
        "Disease Type": "Leukemia;Lymphoma",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04514484\">Pilot Trial of Nivolumab Plus Cabozantinib for Advanced Solid Tumors in Patients with HIV Infection</a>",
        "Disease Type": "AIDS-related Malignancy and Condition;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04460937\">A Phase 1 Trial Combining WEE1 Inhibitor Adavosertib (AZD1775) with Radiation Therapy for Metastatic or Inoperable and Ineligible for Definitive Chemoradiation Esophageal and Gastroesophageal Junction Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05172258\">A Phase 2 Study of Ipatasertib in Combination with Pembrolizumab for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05272384\">A Phase 1 Study of Nivolumab in Combination with ASTX727 in B-cell Lymphoma (NHL or HL) with an Expansion Cohort in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04457596\">The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04394858\">A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05673148\">A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04145115\">A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent WHO Grade 4 Glioma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05235165\">A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma</a>",
        "Disease Type": "Bone Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03595124\">A Randomized Phase 2 Trial of Axitinib/Nivolumab Combination Therapy vs. Single Agent Nivolumab for the Treatment of TFE/Translocation Renal Cell Carcinoma (tRCC) Across All Age Groups</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03550391\">A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) plus Memantine for 5-15 Brain Metastases</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03488693\">Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02201992\">A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04233866\">A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Na\u00efve Metastatic Pancreatic Cancer (GIANT)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04484818\">A Phase III Double Blinded Study of Early Intervention After RADICAl ProstaTEctomy with Androgen Deprivation Therapy with Darolutamide vs. Placebo in Men at Highest Risk of Prostate Cancer Metastasis by Genomic Stratification (ERADICATE)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04530565\">A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) in Adults</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04566328\">Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03180502\">A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients with IDH Mutant, Low to Intermediate Grade Gliomas</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05050084\">Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (GUIDANCE)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04751383\">Phase 1 Trial of Hu5F9-G4 (Magrolimab) Combined with Dinutuximab in Children and Young Adults with Relapsed and Refractory Neuroblastoma or Relapsed Osteosarcoma</a>",
        "Disease Type": "Bone Cancer;Nervous System Cancer (CNS-excluded)",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05096663\">A Phase II/III Study of N-803 (ALT-803) Plus Pembrolizumab Versus Standard of Care in Participants with Stage IV or Recurrent Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy (Lung-MAP Non-Match Sub-Study)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/04496739\">Cluster Randomized Controlled Trial of Patient and Provider Decision Support to Increase Chemoprevention Informed Choice Among Women with Atypical Hyperplasia or Lobular Carcinoma In Situ - Making Informed Choices on Incorporating Chemoprevention Into Care (MiChoice)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Randomized Trial Addressing Cancer-Related Financial Hardship Through Delivery of a Proactive Financial Navigation Intervention (CREDIT)</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04548752\">Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05136196\">Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants with Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study</a>",
        "Disease Type": "Head and Neck Cancer;Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Internet-delivered Management of Pain Among Cancer Treatment Survivors (IMPACTS)</a>",
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma);Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02978625\">A Phase II Study of Talimogene Laherparepvec Followed by Talimogene Laherparepvec + Nivolumab in Refractory T Cell and NK Cell Lymphomas, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, and Other Rare Skin Tumors</a>",
        "Disease Type": "Female Reproductive System Cancer;Lymphoma;Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03317392\">A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03237780\">A Randomized, Phase 2 Trial to Evaluate the Safety and Efficacy of Eribulin Mesylate in Combination with Atezolizumab Compared to Atezolizumab Alone in Subjects with Locally Advanced or Metastatic Transitional Cell Urothelial Cancer Where Cisplatin-Based Treatment is Not an Option</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03983824\">A Phase I Study of M3814 in Combination with MEC in Patients with Relapsed or Refractory Acute Myeloid Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04314401\">Cancer Moonshot Biobank Research Protocol</a>",
        "Disease Type": "Gastrointestinal Cancer;Leukemia;Lung, Mediastinal, and Pleural Cancer;Male Reproductive System Cancer;Myeloma;Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04294628\">Pilot Study of DS-8201a Pharmacodynamics in Patients with HER2-Expressing Advanced Solid Tumors</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04172532\">A Phase 1/2 Study of M3814 (Peposertib) in Combination with Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04514497\">BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients with Advanced Solid Tumors, Phase I Studies with Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA)</a>",
        "Disease Type": "Endocrine Cancer;Gastrointestinal Cancer;Lung, Mediastinal, and Pleural Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04491942\">A Phase 1 Trial of the ATR Inhibitor BAY 1895344 in Combination with Cisplatin and with Cisplatin Plus Gemcitabine in Advanced Solid Tumors with an Emphasis on Urothelial Carcinoma</a>",
        "Disease Type": "Solid Tumor;Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04595747\">Phase 2 Study of Rogaratinib (BAY 1163877) in the Treatment of Patients with Sarcoma Harboring Alterations in Fibroblast Growth Factor Receptor (FGFR) 1-4 and SDH-Deficient Gastrointestinal Stromal Tumor (GIST)</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04802161\">Randomized Phase 2 Study of Daunorubicin and Cytarabine Liposome + Pomalidomide Versus Daunorubicin and Cytarabine Liposome in Newly Diagnosed AML with MDS-Related Changes</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05411094\">A Phase 1 Study of Olaparib in Combination with Durvalumab (MEDI4736) and Concurrent Radiation Therapy Following First-Line Chemotherapy in Locally Advanced Unresectable Pancreatic Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05198843\">Phase Ib/II Study of EPA-Based EphA2 Targeted Therapy for Patients with Metastatic Triple-Negative Inflammatory Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04963153\">Phase Ib Trial of Erdafitinib Combined with Enfortumab Vedotin Following Platinum and PD1/L1 Inhibitors for Metastatic Urothelial Carcinoma with FGFR2/3 Genetic Alterations</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03866382\">A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)</a>",
        "Disease Type": "Germ Cell Cancer;Kidney Cancer;Male Reproductive System Cancer;Miscellaneous and Metastatic Cancer;Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04684368\">A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02595866\">Phase I Study of MK-3475 (Pembrolizumab) in Patients with Human Immunodeficiency Virus (HIV) and Relapsed/Refractory or Disseminated Malignant Neoplasm</a>",
        "Disease Type": "AIDS-related Malignancy and Condition;Gastrointestinal Cancer;Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma);Lung, Mediastinal, and Pleural Cancer;Lymphoma;Skin Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04166318\">A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04559139\">Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03493425\">Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a (and Selected T4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04708418\">Phase II Randomized Study of Neoadjuvant Pembrolizumab Alone or in Combination with CMP-001 in Patients with Operable Melanoma: Efficacy and Biomarker Study</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03504644\">A Phase IB/II Study of Venetoclax (ABT-199) in Combination with Liposomal Vincristine or Vincristine Sulfate in Patients with Relapsed or Refractory T-Cell or B-Cell Acute Lymphoblastic Leukemia</a>",
        "Disease Type": "Leukemia;Lymphoma",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03115333\">Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04852887\">A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04095364\">A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT01993810\">Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04205968\">Randomized Phase II Selection Study of Ramucirumab and Paclitaxel Versus FOLFIRI in Refractory Small Bowel Adenocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03860883\">Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03253679\">A Phase 2 Study of AZD1775, a Wee1 Inhibitor, in Patients with CCNE1 Amplification</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03896503\">Randomized Phase II Trial of Topotecan Plus M6620 (VX-970, Berzosertib) Vs. Topotecan Alone in Patients with Relapsed Small-Cell Lung Cancer</a>",
        "Disease Type": "Endocrine Cancer;Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04284787\">BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2 (BLAST MRD AML-2): A Randomized Phase 2 Study of the Venetoclax, Azacitadine, and Pembrolizumab (VAP) Versus Venetoclax and Azacitadine as First Line Therapy in Older Patients with Acute Myeloid Leukemia (AML) Who Are Ineligible or Who Refuse Intensive Chemotherapy</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04652960\">A Phase I Study with an Expansion Cohort of Duvelisib and Nivolumab in Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS)</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04585958\">A Phase I Study of DS-8201a in Combination with Olaparib in HER2-Expressing Malignancies</a>",
        "Disease Type": "Female Reproductive System Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04345913\">A Phase I/II Trial Evaluating the Safety and Efficacy of Eribulin in Combination with Copanlisib in Patients with Metastatic Triple Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04616534\">Phase 1 Trial of Gemcitabine Combined with the BAY 1895344 ATR Inhibitor with Expansion Cohorts in Advanced Pancreatic and Ovarian Cancer</a>",
        "Disease Type": "Female Reproductive System Cancer;Gastrointestinal Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04576091\">Phase I Trial of BAY 1895344 ATR Inhibitor Combined with Stereotactic Body Radiation Therapy and Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04941287\">A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) with or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05327010\">Phase 2 Trial of the Combination of the BET inhibitor, ZEN003694 (ZEN-3694), and the PARP Inhibitor Talazoparib, in Patients with Molecularly-Selected Solid Tumors (ComBET)</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02474160\">Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)</a>",
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma);Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05610163\">The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing the Efficacy of Triplet Versus Doublet Chemotherapy to Achieve Clinical Complete Response in Patients with Locally Advanced Rectal Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04936230\">Phase II Randomized Trial of Atezolizumab Versus Atezolizumab and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (ART)</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03739814\">A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative, CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05001880\">Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy with or Without Immunotherapy for Peritoneal Mesothelioma</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Mepitel Film for the Reduction of Radiation Dermatitis in Breast Cancer Patients Undergoing Post-Mastectomy Radiation Therapy: A Randomized Phase III Clinical Trial</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04994132\">A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) Plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS)</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04893018\">Phase 1 Study of NT-I7 (rhIL-7-hyFc) for the Treatment of Kaposi Sarcoma in Patients with or Without Infection with HIV</a>",
        "Disease Type": "AIDS-related Malignancy and Condition",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02734537\">Phase II Randomized Trial of Radiotherapy with or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05063552\">A Phase II/III Trial of Chemotherapy + Cetuximab vs Chemotherapy + Bevacizumab vs Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04092283\">Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03712605\">STAMP: Surgically Treated Adjuvant Merkel cell carcinoma with Pembrolizumab, a Phase III Trial</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04216290\">Phase II Study of Bladder-SparIng ChemoradiatioN with Durvalumab in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03941860\">Optimizing Prolonged Treatment In Myeloma Using MRD Assessment (OPTIMUM)</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03851445\">A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">The National Myelodysplastic Syndromes (MDS) Study</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03660826\">A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women with Recurrent, Persistent or Metastatic Endometrial Cancer.: A Platform Trial for Women with Recurrent or Persistent Endometrial Cancer</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02135042\">Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05408845\">A Controlled, Randomized Phase II Trial of Docetaxel Plus Trastuzumab Versus Ado-Trastuzumab Emtansine for Recurrent, Metastatic, or Treatment-Na\u00efve, Unresectable HER2-Positive Salivary Gland Cancer</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Phase I Study of Savolitinib in Recurrent, Progressive or Refractory Medulloblastoma, High-Grade Glioma, Diffuse Intrinsic Pontine Glioma, and CNS Tumors Harboring MET Aberrations</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02834013\">DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) versus Usual Care in Patients with Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04071457\">Phase III Study of Daratumumab/rHuPH20 (NSC- 810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03775265\">Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04269902\">Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study</a>",
        "Disease Type": "Leukemia;Lymphoma",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04989283\">NASSIST (Neoadjuvant Chemoradiation +/- Immunotherapy Before Surgery for Superior Sulcus Tumors): A Randomized Phase II Trial of Trimodality +/- Atezolizumab in Resectable Superior Sulcus Non-Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting</a>",
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma);Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02862275\">A Pilot Study of Atezolizumab (MPDL3280A) Following Adoptive Cell Transfer in Active Hematologic or Solid Tumor Malignancies</a>",
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma);Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02923778\">A Phase 2 Study of Talimogene Laherparepvec (T-VEC) and Radiation in Localized Soft Tissue Sarcoma</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03375307\">A Phase II Study of Olaparib (AZD2281) in Patients with Metastatic/Advanced Urothelial Carcinoma and Other Genitourinary Tumors with DNA-Repair Defects</a>",
        "Disease Type": "Endocrine Cancer;Germ Cell Cancer;Kidney Cancer;Male Reproductive System Cancer;Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03816345\">A Phase Ib Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)</a>",
        "Disease Type": "Female Reproductive System Cancer;Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma);Kidney Cancer;Lung, Mediastinal, and Pleural Cancer;Lymphoma;Skin Cancer;Solid Tumor;Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03842228\">A Phase 1b Biomarker-Driven Combination Trial of Copanlisib, Olaparib, and Durvalumab (MEDI4736) in Patients with Advanced Solid Tumors</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04317105\">A Phase I/II Biomarker Driven Combination Trial of Copanlisib and Immune Checkpoint Inhibitors in Patients with Advanced Solid Tumors</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04557956\">Phase 1/2 Study of an EZH2 Inhibitor (Tazemetostat) in Combination with Dual BRAF/MEK Inhibition in Patients with BRAF- Mutated Metastatic Melanoma Who Progressed on Prior BRAF/MEK Inhibitor Therapy</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04214249\">BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1 (BLAST MRD AML-1): A Randomized Phase 2 Study of the Anti-PD-1 Antibody Pembrolizumab in Combination with Conventional Intensive Chemotherapy as Frontline Therapy in Patients with Acute Myeloid Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04090398\">Phase II Trial of Radium-223 Dichloride in Combination with Paclitaxel in Patients with Bone Metastatic Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04550494\">A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients with Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response</a>",
        "Disease Type": "Breast Cancer;Female Reproductive System Cancer;Gastrointestinal Cancer;Male Reproductive System Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04981509\">A Phase 2 Study of Bevacizumab, Erlotinib and Atezolizumab in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Associated or Sporadic Papillary Renal Cell Cancer</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05053971\">Phase Ib/II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors and Lymphomas</a>",
        "Disease Type": "Gastrointestinal Cancer;Lymphoma;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05422794\">A Phase 1b Trial of ZEN003694 (ZEN-3694) with Pembrolizumab and Nab-Paclitaxel in Patients with Metastatic Triple-Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03375320\">Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients with Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05247905\">Phase II Randomized, Prospective Trial of Lutetium Lu 177 Dotatate PRRT Versus Capecitabine and Temozolomide in Well-Differentiated Pancreatic Neuroendocrine Tumors</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05677490\">Randomized Phase III Trial of mFOLFIRINOX +/- Nivolumab vs. FOLFOX +/- Nivolumab for First-Line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03701308\">A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II/III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03224767\">Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04267848\">Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04929041\">A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05432791\">A Randomized Phase 2/3 Study of Olaparib Plus Temozolomide Versus Investigator's Choice for the Treatment of Patients with Advanced Uterine Leiomyosarcoma After Progression on Prior Chemotherapy</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Tomosynthesis Mammographic Imaging Screening Trial (TMIST)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04316117\">FDG PET to Assess Therapeutic Response in Patients with Bone-Dominant Metastatic Breast Cancer, FEATURE</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05211323\">A Randomized Phase II Trial Evaluating Chemotherapy vs Chemotherapy Plus Bevacizumab and Atezolizumab in Advanced Combined Hepatocellular Carcinoma-Cholangiocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04588246\">Phase III Trial of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for First or Second Distant Brain Relapse After Upfront SRS with Brain Metastasis Velocity >/= 4 Brain Metastases/Year</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05095376\">A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03801876\">Phase III Randomized Trial of Proton Beam Therapy (PBT) Versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03598257\">A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04155034\">MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04511013\">A Randomized Phase 2 Trial of Encorafenib + Binimetinib + Nivolumab Vs Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma with Brain Metastases</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04871529\">Randomized Phase II Trial of Gemcitabine, Avelumab and Carboplatin vs. No Neoadjuvant Therapy Preceding Surgery for Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma: SWOG GAP TRIAL</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Single Arm, Pilot Study of Ramipril for Preventing Radiation- Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "Pilot",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04704661\">Phase 1/1B Study of DS-8201a in Combination with ATR Inhibition (AZD6738) in Advanced Solid Tumors with HER2 Expression (DASH Trial)</a>",
        "Disease Type": "Gastrointestinal Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04190550\">A Phase 1b Study with Expansion Cohort of Escalating Doses of KRT-232 (AMG 232) Administered in Combination with Standard Induction Chemotherapy (Cytarabine and Idarubicin) in Newly Diagnosed Acute Myelogenous Leukemia (AML)</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04840589\">Phase I/Ib Trial Evaluating the Safety and Efficacy of BET Inhibitor, ZEN003694 with PD-1 Inhibitor, Nivolumab with or Without CTLA-4 Inhibitor, Ipilimumab in Solid Tumors</a>",
        "Disease Type": "Female Reproductive System Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05353439\">Phase I Dose Escalation and Expansion Study of Tazemetostat in Combination with Topotecan and Pembrolizumab in Recurrent Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04750954\">A Phase 1b Trial of M3814 (Peposertib) in Combination with Lutetium 177 Dotatate for Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05372614\">Phase I Trial of DS-8201a (Trastuzumab Deruxtecan) in Combination with Neratinib in Solid Tumors with HER2 Alterations</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03609216\">A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients with Muscle-Invasive Bladder Cancer with Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03793166\">PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04071223\">A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients with Advanced Renal Cell Carcinoma with Bone Metastasis (RadiCal)</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03994796\">Genomically-Guided Treatment Trial in Brain Metastases</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHARES)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04546399\">A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination with Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old with First Relapse</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04759586\">A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination with Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02567435\">A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT01896999\">A Phase I Study with an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04444921\">A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Na\u00efve Metastatic Anal Cancer Patients</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04248452\">A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03811015\">A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPSCC</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04671667\">A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03267433\">A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04115631\">A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine, Rituximab and High Dose Cytarabine (BR/CR) 2.) Bendamustine, Rituximab, High Dose Cytarabine and Acalabrutinib (BR/CR-A), and 3.) Bendamustine, Rituximab and Acalabrutinib (BR-A) in Patients <= 70 Years Old with Untreated Mantle Cell Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03793179\">EA5163/S1709 INSIGNA : A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature-Driven Analysis</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04527549\">The BAMM2 (BRAF, Autophagy, MEK Inhibition in Melanoma) Study: A Randomized Double Blind Phase II Study of Dabrafenib and Trametinib with or Without Hydroxychloroquine in Advanced BRAF V600E/K Melanoma with Elevated LDH</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04462406\">A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT00887146\">N0577 (CODEL): Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04729959\">A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05053152\">A Phase II Double-Blinded, Placebo-Controlled Trial of PROstate OligoMETastatic RadiotHErapy with or Without ANdrogen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04739800\">A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination with Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women with Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05256225\">A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined with Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04333537\">Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03137771\">Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03811002\">Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ) for BRAF V600E-Mutant or Trametinib and HCQ for BRAF Fusion/Duplication Positive or NF1-Associated Recurrent or Progressive Gliomas in Children and Young Adults</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04978727\">A Pilot Study of Safety, Tolerability, and Immunological Effects of SurVaxM in Pediatric Patients with Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05071209\">A Phase 1/ 2 Study of BAY 1895344 (elimusertib, NSC#810486) in Pediatric Patients with Relapsed or Refractory Solid Tumors</a>",
        "Disease Type": "Bone Cancer;Lymphoma;Soft Tissue Cancer/Sarcoma;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT01810913\">Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05364645\">A Randomized Phase II Study of Carboplatin and Pemetrexed with or Without Selpercatinib (LY3527723) in Participants with Non-Squamous RET Fusion-Positive Stage IV Non-Small Cell Lung Cancer and Progression of Disease on Prior RET Directed Therapy (Lung-MAP Sub-Study)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05040360\">Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05411081\">A Phase II Randomized Trial of Cabozantinib (NSC #761968) with or Without Atezolizumab (NSC #783608) in Patients with Advanced Papillary Renal Cell Carcinoma (PAPMET2)</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03031730\">A Phase 1 Dose-Escalation and Exploratory Dose Expansion Study of KRT-232 (AMG 232) in Combination with Carfilzomib, Lenalidomide, and Dexamethasone in Relapsed and/or Refractory Myeloma</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03600701\">A Phase 2 Study of Atezolizumab and Cobimetinib in PD-1/PD-L1 Inhibitor Resistant or Refractory Non-Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03831932\">A Phase Ib Study of Osimertinib (AZD9291) and Telaglenastat (CB-839) HCl in Patients with EGFR Mutant Non-Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04052555\">A Phase 1b Study of Berzosertib in Combination with Radiation Therapy to Overcome Therapeutic Resistance in Chemotherapy Resistant Triple Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04216316\">A Phase IB and Randomized Open-Label Phase II Study of Berzosertib (M6620, VX-970) in Combination with Carboplatin/Gemcitabine/Pembrolizumab in Patients with Chemotherapy-Na\u00efve Advanced Non-Small Cell Lung Cancer of Squamous Cell Histology</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04541017\">A Phase 1b/2 Study of Hu5F9-G4 (Magrolimab) in Combination with Mogamulizumab in Relapsed/Refractory Treated T-Cell Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04494113\">A Phase 0 Window-of-Opportunity Pharmacodynamic Trial of Triapine (NSC# 663249) in Uterine Corpus Serous Adenocarcinoma</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "0",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04817241\">Clinical Evaluation of ASTX727 in Combination with Venetoclax All-Oral Therapy vs Standard of Care Cytarabine and Anthracycline Induction Chemotherapy for Younger FLT3WT Patients with ELN High- Risk Acute Myeloid Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04633239\">A Phase 1/1b Dose Escalation Study of Abemaciclib and Olaparib for Recurrent Platinum-Resistant Ovarian Cancer</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05142241\">Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 2 Talazoparib and Temozolomide</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05627245\">Phase 1/Expansion Study of Tazemetostat Plus Belinostat for the Treatment of Relapsed or Refractory Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05241860\">A Phase 2 Trial of ADT Interruption in Patients Responding Exceptionally to AR-Pathway Inhibitor in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): A-DREAM</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03984448\">Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02194738\">Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "SCREENING, OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04242095\">Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05451004\">SPECT-CT Guided Elective Contralateral Neck Treatment [SELECT] for Patients with Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04310007\">A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients with Previously Treated Non-Squamous NSCLC</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03697148\">Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03516279\">BLAST MRD CML 1 Trial: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease (MRD) in Chronic Myeloid Leukemia (CML)- A Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients with CML and Persistently Detectable MRD</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Optimizing Immunosuppression for Steroid-Refractory Anti-PD-1/PD-L1 Pneumonitis</a>",
        "Disease Type": "Immune Disorder (excluding AIDS and malignancy)",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04396860\">A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients with Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II/III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Phase III Trial Of The Impact Of Sentinel Lymph Node Mapping On Patient Reported Lower Extremity Limb Dysfunction In Endometrial Cancer</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04068103\">Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04134260\">Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying treatment for NOde positive prostate cancer by VArying the hormonal ThErapy</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05538897\">A Phase IB and Randomized Phase II Trial of Megestrol Acetate with or Without Ipatasertib in Recurrent or Metastatic Endometrioid Endometrial Cancer</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03952585\">A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04402788\">RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04539366\">GD2-CAR PERSIST: Production and Engineering of GD2-Targeted, Receptor Modified T Cells (GD2CART) for Osteosarcoma or Neuroblastoma to Increase Systemic Tumor Exposure</a>",
        "Disease Type": "Bone Cancer;Nervous System Cancer (CNS-excluded)",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05286801\">A Phase 1/2 Study of Tiragolumab (NSC# 827799) and Atezolizumab (NSC# 783608) in Patients with Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors</a>",
        "Disease Type": "CNS Cancer (Primary tumor);Kidney Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03678025\">Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04625647\">A Phase II Study of Sotorasib (AMG 510) in Participants with Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04510597\">Phase III Trial of Immunotherapy-Based Combination Therapy with or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04647916\">A Phase II Trial of Sacituzumab Govitecan (IMMU-132) (NSC #820016) for Patients with HER2-Negative Breast Cancer and Brain Metastases</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Cluster Randomized Trial Comparing An Educationally Enhanced Genomic Tumor Board (EGTB) Intervention to Usual Practice to Increase Evidence-Based Genome-Informed Therapy</a>",
        "Disease Type": "AIDS-related Malignancy and Condition;Bone Cancer;Breast Cancer;CNS Cancer (Primary tumor);Endocrine Cancer;Eye Cancer;Female Reproductive System Cancer;Gastrointestinal Cancer;Germ Cell Cancer;Head and Neck Cancer;Kidney Cancer;Lung, Mediastinal, and Pleural Cancer;Male Reproductive System Cancer;Miscellaneous and Metastatic Cancer;Nervous System Cancer (CNS-excluded);Skin Cancer;Soft Tissue Cancer/Sarcoma;Solid Tumor;Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03141684\">A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03041688\">A Phase 1B Study of KRT-232 (AMG-232) in Combination with Decitabine in Acute Myeloid Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03212274\">A Phase 2 Study of the PARP Inhibitor Olaparib (AZD2281) in IDH1 and IDH2 Mutant Advanced Solid Tumors</a>",
        "Disease Type": "CNS Cancer (Primary tumor);Gastrointestinal Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03854474\">A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03604978\">A Phase I/II Study of Nivolumab Plus or Minus Ipilimumab in Combination with Multi-Fraction Stereotactic Radiosurgery for Recurrent High-Grade Radiation-Relapsed Meningioma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03878095\">A Phase II Study of Olaparib and AZD6738 in Isocitrate Dehydrogenase (IDH) Mutant Solid Tumors</a>",
        "Disease Type": "Gastrointestinal Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03953898\">The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04068194\">A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies</a>",
        "Disease Type": "Gastrointestinal Cancer;Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04197713\">Phase I Sequential Trial of Agents Against DNA Repair (STAR)</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04847453\">A Phase 1/1a Study of Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for Relapsed/Refractory Light Chain Amyloidosis</a>",
        "Disease Type": "Immune Disorder (excluding AIDS and malignancy)",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05111561\">A Phase 1 Study of ZEN003694 in Combination with Binimetinib in Solid Tumors with RAS Pathway Alterations and Triple Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer;Solid Tumor",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05172245\">Phase I/Ib Study of AKT Inhibitor Ipatasertib with Chemoradiation for Locally Advanced Head and Neck Cancer</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05372640\">A Phase 1 Study of BET Bromodomain Inhibitor ZEN003694 in Combination with the CDK4/6 Inhibitor Abemaciclib in Patients with NUT Carcinoma and Other Solid Tumors</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer;Solid Tumor",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05198830\">A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination with Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04164082\">Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04455750\">CASPAR - A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05092958\">MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab vs Maintenance Avelumab After First-Line Platinum-Based Chemotherapy in Patients with Metastatic Urothelial Cancer</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03150693\">A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Oxybutynin versus Placebo for Treatment of Hot Flashes in Men Receiving Androgen Deprivation Therapy</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03067181\">A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors</a>",
        "Disease Type": "Germ Cell Cancer;Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02582697\">A Randomized Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumors</a>",
        "Disease Type": "Germ Cell Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04751370\">A Phase II Study of Neoadjuvant Nivolumab Plus Ipilimumab and Short-Course Radiation in MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04181060\">Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04423211\">Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05289687\">A Phase II Study of Daratumumab-Hyaluronidase for Chemotherapy-Relapsed/Refractory Minimal Residual Disease (MRD) in T Cell Acute Lymphoblastic Leukemia (T-ALL)</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials</a>",
        "Disease Type": "Bone Cancer;Breast Cancer;CNS Cancer (Primary tumor);Endocrine Cancer;Female Reproductive System Cancer;Gastrointestinal Cancer;Germ Cell Cancer;Leukemia;Lymphoma;Miscellaneous and Metastatic Cancer;Skin Cancer;Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "Pilot",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03180268\">Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05438212\">A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients with Resectable Brain Metastases</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">FORTE (Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or fewer Brain Metastases from Small Cell Lung Cancer</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03186898\">A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT02997228\">Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04037254\">Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen DeprIvation Therapy (ADT) in High Risk Prostate Cancer (with Initial Phase I) (NADIR*)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "I/II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04513717\">Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05050162\">Randomized Phase II/III Trial of Radiation with Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation with Weekly Cisplatin at 40 mg/m2 for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04158141\">Phase III Randomized Trial of Pleurectomy/Decortication Plus Systemic Therapy with or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) For Malignant Pleural Mesothelioma (MPM)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Randomized Phase III Double-Blind Clinical Trial Evaluating The Effect Of Immune-Enhancing Nutrition On Radical Cystectomy Outcomes (SIMmune)</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03269669\">Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/\">A Prospective Observational Cohort Study to Assess miRNA 371 For Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors</a>",
        "Disease Type": "Germ Cell Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04799275\">A Phase II/III Randomized Study of R-MiniCHOP with or Without CC-486 (Oral Azacitidine) in Participants Age 75 Years or Older with Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas with MYC AND BCL2 and/or BCL6 Rearrangements</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05308446\">Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=Tumor-Agnostic+Precision+Immunooncology+and+Somatic+Targeting+Rational+for+You+(TAPISTRY)+Phase+II+Platform+Trial&cntry=US\">Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial</a>",
        "Disease Type": "NTRK, ROS1, ALK, AKT, PIK3CA, BRAF II/III, RET",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+I/II+Study+of+the+SV-BR-1-GM+Regimen+in+Metastatic+or+Locally+Recurrent+Breast+Cancer+Patients+in+Combination+with+Retifanlimab&cntry=US\">A Phase I/II Study of the SV-BR-1-GM Regimen in Metastatic or Locally Recurrent Breast Cancer Patients in Combination with Retifanlimab</a>",
        "Disease Type": "HER2+, HER2-, ER+, PR+, ER-, PR-, TNBC",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+First-in-human+Study+of+Highly+Selective+FGFR2+Inhibitor,+RLY-4008,+in+Patients+with+Intrahepatic+Cholangiocarcinoma+(ICC)+and+Other+Advanced+Solid+Tumors&cntry=US\">A First-in-human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Intrahepatic Cholangiocarcinoma (ICC) and Other Advanced Solid Tumors</a>",
        "Disease Type": "FGFR2 alterations",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Randomized+Phase+3+Study+of+MRTX849+in+Combination+with+Cetuximab+Versus+Chemotherapy+in+Patients+with+Advanced+Colorectal+Cancer+with+KRAS+G12C+Mutation+with+Disease+Progression+On+or+After+Standard+First-Line+Therapy&cntry=US\">A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy</a>",
        "Disease Type": "KRAS G12C",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+1+Open-label+Dose+Escalation+Study+of+CGX1321+Subjects+with+Advanced+Solid+Tumors+with+Expansion+in+Advanced+Gastrointestinal+Tumors+and+Phase+1b+Study+of+CGX1321+in+Combination+with+Pembrolizumab+in+Subjects+with+Advanced+Colorectal+Cancer+or+in+Combination+with+Encorafenib+++Cetuximab+in+Subjects+with+BRAF+V600E+Mutated+Advanced+Colorectal+Cancer&cntry=US\">A Phase 1 Open-label Dose Escalation Study of CGX1321 Subjects with Advanced Solid Tumors with Expansion in Advanced Gastrointestinal Tumors and Phase 1b Study of CGX1321 in Combination with Pembrolizumab in Subjects with Advanced Colorectal Cancer or in Combination with Encorafenib + Cetuximab in Subjects with BRAF V600E Mutated Advanced Colorectal Cancer</a>",
        "Disease Type": "RSPO2, RSPO3, RNF43, BRAF V600E",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+1/1b+Open-label,+Multicenter+Study+to+Investigate+the+Safety,+Tolerability,+Pharmacokinetics,+and+Antitumor+Activity+of+KIN-2787+in+Participants+with+BRAF+and/or+NRAS+Mutation-positive+Solid+Tumors&cntry=US\">A Phase 1/1b Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of KIN-2787 in Participants with BRAF and/or NRAS Mutation-positive Solid Tumors</a>",
        "Disease Type": "BRAF Class I, II, and III; Melanoma NRAS",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=Crestone:+A+Phase+2+Study+of+Seribantumab+in+Adult+Patients+with+Neuregulin-1+(NRG1)+Fusion+Positive+Locally+Advanced+or+Metastatic+Solid+Tumors&cntry=US\">Crestone: A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors</a>",
        "Disease Type": "NRG1",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+1/2+Multicenter+Study+of+the+Safety,+Pharmacokinetics,+and+Preliminary+Efficacy+of+APL-101+in+Subjects+with+Non-Small+Cell+Lung+Cancer+with+c-Met+EXON+14+Skip+Mutations+and+c-Met+Dysregulation+Advanced+Solid+Tumors&cntry=US\">A Phase 1/2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors</a>",
        "Disease Type": "c-Met",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+1b/2,+Open+Label+Study+of+DAY101+Monotherapy+or+Combination+with+Other+Therapies+for+Patients+with+Recurrent,+Progressive,+or+Refractory+Solid+Tumors+and+MAPK+Pathway+Aberrations&cntry=US\">A Phase 1b/2, Open Label Study of DAY101 Monotherapy or Combination with Other Therapies for Patients with Recurrent, Progressive, or Refractory Solid Tumors and MAPK Pathway Aberrations</a>",
        "Disease Type": "BRAF Fusions, CRAF/RAF1 Fusions and Amplifications",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Multi-arm,+Phase+II,+Open-Label,+Multicentre+Study+to+Assess+the+Preliminary+Efficacy+of+RXC004+in+Monotherapy+and+in+Combination+with+Nivolumab,+in+Patients+with+Ring+Finger+Protein+43+(RNF43)+or+R-spondin+(RSPO)+Aberrated,+Metastatic,+Microsatellite+Stable,+Colorectal+Cancer+who+have+Progressed+following+Therapy+with+Current+Standard+of+Care&cntry=US\">A Multi-arm, Phase II, Open-Label, Multicentre Study to Assess the Preliminary Efficacy of RXC004 in Monotherapy and in Combination with Nivolumab, in Patients with Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer who have Progressed following Therapy with Current Standard of Care</a>",
        "Disease Type": "RNF43 or RSPO2, RSPO3",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+2+Trial+of+MRTX849+in+Combination+with+Pembrolizumab+in+Patients+with+Advanced+Non-Small+Cell+Lung+Cancer+with+KRAS+G12C+Mutation&cntry=US\">A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation</a>",
        "Disease Type": "KRAS G12C",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+2+multi-center+open-label+basket+trial+of+nab-sirolimus+for+adult+and+adolescent+patients+with+malignant+solid+tumors+harboring+pathogenic+inactivating+alterations+in+TSC1+or+TSC2+genes&cntry=US\">A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes</a>",
        "Disease Type": "TSC1; TSC2",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+I/II+Study+of+MCLA-128,+a+full+length+IgG1+Bispecific+Antibody+Targeting+HER2+and+HER3,+in+Patients+with+Solid+Tumors&cntry=US\">A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors</a>",
        "Disease Type": "NRG1",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+phase+1/2+study+of+IDE196+in+patients+with+solid+tumors+harboring+GNAQ/11+mutations+or+PRKC+fusions&cntry=US\">A phase 1/2 study of IDE196 in patients with solid tumors harboring GNAQ/11 mutations or PRKC fusions</a>",
        "Disease Type": "GNAQ, GNA11",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+1/2+Multiple+Expansion+Cohort+Trial+of+MRTX849+in+Patients+with+Advanced+Solid+Tumors+with+KRAS+G12C+Mutation&cntry=US\">A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation</a>",
        "Disease Type": "KRAS G12C, STK 11",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+1/2a+Study+to+Assess+the+Safety,+Pharmacokinetics,+and+Pharmacodynamics+of+PLX8394+in+Patients+with+Advanced,+Unresectable+Solid+Tumors&cntry=US\">A Phase 1/2a Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PLX8394 in Patients with Advanced, Unresectable Solid Tumors</a>",
        "Disease Type": "BRAF",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+2+Basket+Study+of+Milademetan+in+Advanced/Metastatic+Solid+Tumors&cntry=US\">A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors</a>",
        "Disease Type": "Wild-type (WT) TP53 and MDM2",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=PBI-200-101+A+Phase+1/2+Study+of+PBI-200+in+Subjects+with+NTRK-Fusion-Positive+Advanced+or+Metastatic+Solid+Tumors&cntry=US\">PBI-200-101 A Phase 1/2 Study of PBI-200 in Subjects with NTRK-Fusion-Positive Advanced or Metastatic Solid Tumors</a>",
        "Disease Type": "NTRK-fusion-positive or NTRK-amplified, EWSR1-WT1-fusion-positive",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+2+Master+Protocol+to+assess+the+efficacy+and+safety+of+FORE8394,+an+inhibitor+of+BRAF+class+1+and+class+2+alterations,+in+participants+with+cancer+harboring+BRAF+alterations&cntry=US\">A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations</a>",
        "Disease Type": "BRAF",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/results?term=A+Phase+2,+Multi-Center+Study+Evaluating+the+Safety+and+Efficacy+of+ENV-101+(Taladegib)+in+Patients+with+Advanced+Solid+Tumors+Harboring+PTCH1+Loss+of+Function+Mutations&cntry=US\">A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients with Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations</a>",
        "Disease Type": "PTCH1",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.thewisdomstudy.org/\">Women Informed to Screen Depending on Measures of Risk (Wisdom Study)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://mbcproject.org/\">Metastatic Breast Cancer Project</a>",
        "Disease Type": "Metastatic Breast Cancer",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://mpcproject.org/\">Metastatic Prostate Cancer Project</a>",
        "Disease Type": "Metastatic Prostate Cancer",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://escproject.org/\">Esophageal and Stomach Cancer Project</a>",
        "Disease Type": "Esophageal and Stomach Cancer",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://braintumorproject.org/\">Brain Tumor Project</a>",
        "Disease Type": "Primary Brain Tumor",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://ascproject.org/\">Angiosarcoma Project</a>",
        "Disease Type": "Angiosarcoma",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://inheritedcancer.net/\">Inherited Cancer Registry - Hereditary Cancers Inherited Cancer - Genetics</a>",
        "Disease Type": "Inherited Cancer - Genetics",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04214262\">A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC</a>",
        "Disease Type": "Non-small Cell Lung Cancer",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.joinallofus.org/\">All of Us Research Program</a>",
        "Disease Type": "Healthy Volunteers",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.adventisthealth.org/bakersfield/services/cancer-center/\">Aromatherapy in patients receiving chemotherapy in the outpatient setting</a>",
        "Disease Type": "All Cancer Types",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05174169\">Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active*",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05050084\">Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)</a>",
        "Disease Type": "Prostate Cancer",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT03952585\">De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active*",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    }
]
